Teva sues Mylan over Copaxone patent infringement

18-01-2017

Teva sues Mylan over Copaxone patent infringement

Photo: Courtesy of Teva

Teva has sued Mylan for alleged patent infringement over Copaxone (glatiramer acetate injection), a treatment for patients with relapsing-remitting forms of multiple sclerosis.


Teva, Mylan, patent, Copaxone, ANDA, IPR, USPTO

LSIPR